Growth Metrics

China Pharma Holdings (CPHI) Inventory Average (2016 - 2025)

Historic Inventory Average for China Pharma Holdings (CPHI) over the last 15 years, with Q3 2025 value amounting to $2.7 million.

  • China Pharma Holdings' Inventory Average rose 194.44% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 194.44%. This contributed to the annual value of $3.4 million for FY2024, which is 157.95% down from last year.
  • China Pharma Holdings' Inventory Average amounted to $2.7 million in Q3 2025, which was up 194.44% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, China Pharma Holdings' Inventory Average registered a high of $3.8 million during Q3 2023, and its lowest value of $2.7 million during Q3 2024.
  • Over the past 5 years, China Pharma Holdings' median Inventory Average value was $3.2 million (recorded in 2024), while the average stood at $3.2 million.
  • Per our database at Business Quant, China Pharma Holdings' Inventory Average surged by 3074.87% in 2023 and then crashed by 3076.33% in 2024.
  • China Pharma Holdings' Inventory Average (Quarter) stood at $3.0 million in 2021, then decreased by 3.1% to $2.9 million in 2022, then skyrocketed by 30.75% to $3.8 million in 2023, then tumbled by 30.02% to $2.7 million in 2024, then rose by 1.54% to $2.7 million in 2025.
  • Its Inventory Average stands at $2.7 million for Q3 2025, versus $2.7 million for Q2 2025 and $2.8 million for Q1 2025.